Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

PURPOSE: Cisplatin or cetuximab combined with radiotherapy (RT) each yield superior survival in locally advanced squamous cell head and neck cancer (LA-SCCHN) compared to RT alone. E3303 evaluated the triple combination. EXPERIMENTAL DESIGN: Patients with stage IV unresectable LA-SCCHN received a lo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Egloff, Ann Marie, Lee, Ju-Whei, Langer, Corey J., Quon, Harry, Vaezi, Alec, Grandis, Jennifer R., Seethala, Raja R., Wang, Lin, Shin, Dong M., Argiris, Athanassios, Yang, Donghua, Mehra, Ranee, Ridge, John Andrew, Patel, Urjeet A., Burtness, Barbara A., Forastiere, Arlene A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184913/
https://ncbi.nlm.nih.gov/pubmed/25107914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0051
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items